已收盤 12-12 16:00:00 美东时间
-0.220
-6.98%
The latest announcement is out from Cassava Sciences ( ($SAVA) ). Cassava Scien...
12-03 19:54
Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 12.1% to $8.18 during Mond...
11-25 05:05
Shares of Cassava Sciences (SAVA) added ~5% in the premarket on Friday after Richard Barry, President and Chief Executive Officer of the Alzheimer’s drug developer, purchased company stock after nearl...
11-21 20:37
Cassava Sciences (SAVA) has filed a shelf registration statement with the SEC to offer up to $200 million worth of mixed securities, including common stock, preferred stock, depository shares, warrant...
11-13 19:37
Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.27) by 18.52 percent. This is a 62.07 percent increase over losses of $(0.58) per share from
11-12 21:12
Cassava Sciences reported third-quarter 2025 financial results with a net loss of $10.8 million and $106.1 million in cash. The company advanced simufilam for TSC-related epilepsy, targeting a 2026 clinical study, and appointed Dawn C. Bir to its board.
11-12 13:00
- Strategic PQC-related and Edge design wins expected to lead to double digit growth in 2026 and beyond - KFAR SAVA, Israel, Oct. 30, 2025 /PRNewswire/ -- Silicom Ltd. (NASDAQ: SILC), a lea...
10-30 20:15
KFAR SAVA, Israel, Oct. 28, 2025 /PRNewswire/ -- Silicom Ltd. (NASDAQ: SILC), a leading provider of networking and data infrastructure solutions, today announced that an existing customer, a...
10-28 20:30
Cassava Sciences (NASDAQ:SAVA) shares rose as much as 6% premarket on Friday after a U.S. court dismissed a criminal case against Hoau-Yan Wang, a former scientific collaborator and advisor who conduc...
10-24 20:43